<?xml version="1.0" encoding="UTF-8"?>
<ref id="B26-ijms-21-03732">
 <label>26.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Meuleman</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Hesselgesser</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Paulson</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Vanwolleghem</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Desombere</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Reiser</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Leroux-Roels</surname>
    <given-names>G.</given-names>
   </name>
  </person-group>
  <article-title>Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo</article-title>
  <source>Hepatology</source>
  <year>2008</year>
  <volume>48</volume>
  <fpage>1761</fpage>
  <lpage>1768</lpage>
  <pub-id pub-id-type="doi">10.1002/hep.22547</pub-id>
  <pub-id pub-id-type="pmid">19030166</pub-id>
 </element-citation>
</ref>
